See-Mode
See-Mode Technologies is a MedTech company specializing in AI-enhanced ultrasound reporting to improve diagnostic accuracy and efficiency. Their platform automatically analyzes thyroid and breast ultrasound images, producing fast and accurate radiology reports. See-Mode detects, sizes, and characterizes nodules, generating a complete TI-RADS sonographer worksheet and preliminary radiologist impressions. In breast imaging, the software identifies lesions and automates BI-RADS reporting, detailing both characteristics and suspicion levels. By reducing inter-operator variability and reporting errors, See-Mode enhances diagnostic confidence and consistency. See-Mode identifies breast lesions in ultrasound imaging and automates BI-RADS reporting, including both characteristics and suspicion levels. See-Mode automatically detects sizes, and characterizes thyroid nodules, producing a complete TI-RADS sonographer worksheet and preliminary radiologist impressions.
Learn more
Hermia
Hermia is a sophisticated, vendor-neutral molecular imaging suite designed to unify and streamline clinical workflows across nuclear medicine, PET/SPECT/CT/MR reviewing, and advanced imaging analysis while supporting scanners and DICOM data from any manufacturer, enabling facilities to choose hardware freely and consolidate multiple legacy systems into one platform. It offers high-performance multimodality image display and analysis with intuitive, customizable workflows that accelerate reporting, improve data visualization, and reduce manual steps from acquisition through interpretation, facilitating fast and accurate review of PET/CT, SPECT/CT, and PET/MR studies. Hermia’s comprehensive toolset includes optimized SPECT reconstruction for diverse procedures and radio-pharmaceuticals, a broad nuclear medicine processing toolkit for osteology, gastroenterology, nephrology, and endocrinology, and specialized modules for pneumology with lung function and SPECT V/Q quantification.
Learn more
Infervision
Infervision is a leading AI medical technology company established in 2016, focusing on improving multidisciplinary services and operations with AI. They offer cutting-edge AI products that support medical professionals in all areas, from disease screening and diagnosis to intervention and treatment, patient management, and medical research. Their solutions include InferRead CT Lung for lung nodule detection from chest CT, InferRead DR Chest for detecting chest abnormalities from chest X-rays, InferRead CT Coronary for identifying coronary artery stenosis in coronary CTA, InferRead CT Stroke for triaging hemorrhage from brain CT, InferRead CT Bone for identifying chest fractures from chest CT, and InferRead CT Pneumonia for identifying and triaging pneumonia from chest CT. Additionally, they offer InferOperate for 3D reconstruction in thoracic, liver, and urological surgeries, InferCare for patient management and image follow-up, and InferScholar as an AI-enabled medical research tool.
Learn more
ClearRead Xray
Riverain Technologies' ClearRead Xray is a suite of five FDA-cleared applications designed to enhance the efficiency and accuracy of chest X-ray interpretation across healthcare enterprises without necessitating additional equipment, procedures, or radiation exposure. The platform employs unique suppression technology to provide an unobstructed view of the chest, facilitating the rapid and accurate detection of cardiothoracic diseases. Key features include the production of bone-suppressed images for improved visualization, identification of potential lung cancer nodules, reduction in portable X-ray reading time, automatic comparison of findings with prior exams to highlight changes, and enterprise-wide compatibility across various manufacturers and imaging protocols. Notably, ClearRead Xray Bone Suppress increases the visibility of soft tissue by suppressing bone structures in digital images, aiding radiologists in detecting previously missed nodules.
Learn more